A detailed history of Lindbrook Capital, LLC transactions in Certara, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 17 shares of CERT stock, worth $169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 179 90.5%
Holding current value
$169
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$10.46 - $16.58 $1,694 - $2,685
-162 Reduced 90.5%
17 $0
Q2 2024

Jul 31, 2024

SELL
$13.36 - $18.94 $173 - $246
-13 Reduced 6.77%
179 $2,000
Q4 2023

Jan 31, 2024

BUY
$12.12 - $18.19 $945 - $1,418
78 Added 68.42%
192 $3,000
Q4 2022

Jan 24, 2023

BUY
$10.7 - $17.84 $1,027 - $1,712
96 Added 533.33%
114 $0
Q3 2022

Nov 10, 2022

BUY
$12.84 - $24.13 $231 - $434
18 New
18 $0

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.59B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.